POSTER SESSION IV
Tuesday, March 1, 2011 — 1:00 PM - 4:30 PM
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
NEUROPATHOLOGY
Poster#
Title and Authors
Itinerary Planner
221
Isocitrate Dehydrogenase 1 (IDH1) R132H Mutation Is Not Detected in Angiocentric Glioma.
(1631)
A Raghunathan, A Olar, H Vogel, JR Parker, SC Coventry, R Debski, CT Albarracin, KD Aldape, DP Cahill, SZ Powell, GN Fuller - University of Texas M.D. Anderson Cancer Center, Houston; The Methodist Hospital, Houston, TX; Baylor College of Medicine, Houston, TX; Stanford University School of Medicine, CA; University of Louisville Health Science Center, KY; Kosair Children's Hospital, Louisville, KY
Pilomyxoid Astrocyoma: Report of Fourteen Cases with Clinicopathological Features.
(1611)
S Epari, P Patil, V Tiwari, R Jalali, A Moiyadi, T Gupta, M Bal, P Shetty, S Kane - Tata Memorial Centre, Mumbai, Maharashtra, India
Pathological Characteristics of Pediatric Intracranial Pilocytic Astrocytomas and Their Impact on Outcome in Three Geographically Distinct Regions: A Multi-institutional Study.
(1612)
A Ersen, T Tihan, I Qaddoumi, M Alsughayer, S Ozuysal, M AlHoussaini, A Baneerjee - Dokuz Eylul University, Izmir, Turkey; University of California San Francisco; St Jude Children's Research Hospital, Memphis, TN; King Hussein Cancer Center, Amman, Jordan; Uludag University, Bursa, Turkey
Phenotypic Variations in NF1-Associated Low Grade Gliomas: Possible Role for Increased mTOR Activation in a Subset.
(1619)
M Jentoft, C Giannini, L Cen, BW Scheithauer, B Hoesley, JN Sarkaria, PC Abell-Aleff, Y Li, FJ Rodriguez - Mayo Clinic, Rochester, MN
Immunohistochemical Assessment of Neuroepithelial Markers and Hamartin/Tuberin Expression in Subependymal Giant Cell Astrocytoma (SEGA): Further Evidence for Ambiguous Differentiation and mTOR Signal Transduction Dysregulation.
(1606)
BD Barrows, MJ Rutkowski, H Gultekin, A Parsa, T Tihan - UCSF, San Francisco, CA; OHSU, Portland, OR
Are There Any Differences in the Expression of IDH1 and P53 Proteins between Astrocytoma and Oligodendroglioma?
(1640)
M Zheng, S Sharma - Medical College of Georgia, Augusta
Nestin, an Important Marker for Differentiating Oligodendroglioma from Astrocytic Tumors.
(1604)
SH Abu-Farsakh, IA Sbeih, HA Abu-Farsakh - Jordan University, Amman, Jordan; Ibn Hytham Hospital, Amman, Jordan; First Medical Lab, Amman, Jordan
Genetic Alteration of Pediatric Glioblastomas.
(1634)
J Seo, JK Myung, S-J Byun, SH Kim, S-H Park - Seoul National University Hospita, Korea; Yonsei University Hospital, Seoul, Korea
Absence of IDH1 R132H Mutation Predicts Rapid Progression of Non-Enhancing Diffuse Glioma in Older Adults.
(1629)
A Olar, A Raghunathan, CT Albarracin, KD Aldape, DP Cahill, SZ Powell, C Goodman, GN Fuller - Baylor College of Medicine, Houston, TX; University of Texas M.D. Anderson Cancer Center, Houston; The Methodist Hospital, Houston, TX
Analysis of Glioma Stem Cell Markers and Genomic Alterations in Primary and Recurrent Glioblastomas.
(1605)
CL Appin, MJ Schniederjan, E Van Meir, GM Mastrogianakis, DJ Brat - Emory University School of Medicine, Atlanta, GA
Unusual Histological Findings in a Cohort of Gliomas with High Grade Features: A Clinicopathological Study of 5 Cases at a Single Institution.
(1638)
Y Sun, X Song, I Kureshi, T Ciesielski, S Mandavilli - Hartford Hospital, CT
Inhibition of Signal Transducer and Activator of Transcription 3 (STAT3) by the Multi-Kinase Inhibitor Sorafenib Overcomes TRAIL-Resistance in Malignant Glioma Cells.
(1636)
MD Siegelin - Columbia University College of Physicians & Surgeons, New York, NY
MGMT Promoter Methylation in Gliomas. Comparison of Methods: Methylation Specific PCR (MSP) vs Pyrosequencing.
(1608)
G DeMaglio, L Morandi, G Falconieri, GM Guarrera, M Skrap, G Tallini, S Pizzolitto - University Hospital, Udine, Italy; University Hospital Bellaria, Bologna, Italy
Choroid Plexus Carcinoma in Adults: Clinicopathologic, Immunohistochemical, and Imaging Studies of Cases Presenting at Unusual Sites.
(1637)
SC Smith, JE Madory, C Welsh, MT Smith, M Blaivas - University of Michigan Health System, Ann Arbor; Medical University of South Carolina, Charleston
Embryonal Malignant Neuroepithelial Tumors of the Cerebellum with No Neuroblastic Differentiation: Medulloblastoma Variant or Different Entity?
(1609)
B Ellezam, V Mehta, GR Courteau, AM Adesina - Texas Children's Hospital, Baylor College of Medicine, Houston
Meningioangiomatosis: The Pathological Spectrum of Lesions in Four Cases Including the First Report of a Fetal Case.
(1614)
S Hakim, E Gelpi, E Martinez-Saez, A Ortega-Aznar, A Nadal, T Ribalta - Hospital Clinic, Barcelona, Spain; Hospital Vall d'Hebron, Barcelona, Spain
TMA Analysis of Invasive and Non-Invasive Meningiomas.
(1633)
F Salehi, S Jalali, K Burrell, G Zadeh, S Croul - University Health Network, Toronto, ON, Canada
Uncommon Patterns and Clinical Features of Peripheral Nerve Sheath Tumors of the Spinal Cord: UCSF Experience 1983-2010.
(1628)
A Naujokas, P Modera, P Weinstein, T Tihan - University of California . San Francisco
Challenges in the Differential Diagnosis and Subtyping of Primary Central Nervous System Lymphomas.
(1624)
EF Krasik, M Pekmezci, T Tihan - University of California San Francisco
Osteopontin Immunoexpression in Primary Central Nervous System Lymphoma, and Comparison with Nodal and Extranodal Diffuse Large B-Cell Lymphoma.
(1639)
J Yuan, K Gu, S Sharma - Medical College of Georgia, Augusta; University Hospital, Augusta, GA
Primary Hematolymphoid Lesions of the Meninges: A Clinicopathologic Study of 9 Cases Presenting as Mimics of Meningioma.
(1617)
CB Hutchinson, I Siddiqi, P Buckley, A Buckley, E Wang - Duke University Medical Center, Durham, NC
Luminal A Subtype Predicts Improved Survival in Patients with Metastatic Breast Carcinoma to the Brain.
(1625)
SE Martin, SS Badve, P Steeg, EM Hattab - Indiana University School of Medicine, Indianapolis; National Cancer Institute, Bethesda, MD
Neural Stem Cells Deficient in BAX and BAK Manifest Profound Hyperplasia and Tumorigenesis.
(1621)
SG Katz, JK Fisher, KL Ligon, LD Walensky - Brigham and Women's Hospital, Boston, MA; Dana-Farber Cancer Institute and Children's Hospital Boston, Boston, MA; Dana Farber Cancer Institue, Harvard Medical School, Boston, MA
Applications of Optical Coherence Tomography (OCT) in Neuropathology.
(1622)
T-R Kiehl, BA Standish, VX Yang - University Health Network, Toronto, ON, Canada; Ryerson University, Toronto, ON, Canada
button next to any title to add to Itinerary Planner...
Add
